Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Silvia Mandel

Showing results (21-30 of 46) with videos related to

Pageof 5
Sort By:
Brain Research. Brain Research Reviews|April 27, 2005
Mechanism of neuroprotective action of the anti-Parkinson drug rasagiline and its derivativesSilvia Mandel, Orly Weinreb, Tamar Amit, et al.
Free Radical Biology & Medicine|February 5, 2013
Targeting dysregulation of brain iron homeostasis in Parkinson's disease by iron chelatorsOrly Weinreb, Silvia Mandel, Moussa B H Youdim, et al.
Progress in Neurobiology|July 31, 2007
Iron dysregulation in Alzheimer's disease: multimodal brain permeable iron chelating drugs, possessing neuroprotective-neurorescue and amyloid precursor protein-processing regulatory activities as therapeutic agentsSilvia Mandel, Tamar Amit, Orit Bar-Am, et al.
Journal of Neurochemistry|December 9, 2010
The relevance of iron in the pathogenesis of Parkinson's diseaseJeswinder Sian-Hülsmann, Silvia Mandel, Moussa B H Youdim, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|December 1, 2007
Targeting multiple Alzheimer's disease etiologies with multimodal neuroprotective and neurorestorative iron chelatorsTamar Amit, Yael Avramovich-Tirosh, Moussa B H Youdim, et al.
Neurotoxicity Research|April 24, 2003
Early and late molecular events in neurodegeneration and neuroprotection in Parkinson's disease MPTP model as assessed by cDNA microarray; the role of ironMoussa B.H. Youdim, Edna Grünblatt, Yona Levites, et al.
Molecular Nutrition & Food Research|February 14, 2006
Green tea catechins as brain-permeable, natural iron chelators-antioxidants for the treatment of neurodegenerative disordersSilvia Mandel, Tamar Amit, Lydia Reznichenko, et al.
Antioxidants & Redox Signaling|January 26, 2010
Neuroprotective multifunctional iron chelators: from redox-sensitive process to novel therapeutic opportunitiesOrly Weinreb, Tamar Amit, Silvia Mandel, et al.
Journal of Alzheimer'S Disease : JAD|June 18, 2010
Propargylamine containing compounds as modulators of proteolytic cleavage of amyloid-beta protein precursor: involvement of MAPK and PKC activationOrit Bar-Am, Tamar Amit, Orly Weinreb, et al.
CNS Drugs|July 23, 2003
Neuroprotective strategies in Parkinson's disease : an update on progressSilvia Mandel, Edna Grünblatt, Peter Riederer, et al.
Pageof 5

Showing results (21-30 of 46) with videos related to

Sort By:
Pageof 5
Brain Research. Brain Research Reviews|April 27, 2005
Mechanism of neuroprotective action of the anti-Parkinson drug rasagiline and its derivativesSilvia Mandel, Orly Weinreb, Tamar Amit, et al.
Free Radical Biology & Medicine|February 5, 2013
Targeting dysregulation of brain iron homeostasis in Parkinson's disease by iron chelatorsOrly Weinreb, Silvia Mandel, Moussa B H Youdim, et al.
Progress in Neurobiology|July 31, 2007
Iron dysregulation in Alzheimer's disease: multimodal brain permeable iron chelating drugs, possessing neuroprotective-neurorescue and amyloid precursor protein-processing regulatory activities as therapeutic agentsSilvia Mandel, Tamar Amit, Orit Bar-Am, et al.
Journal of Neurochemistry|December 9, 2010
The relevance of iron in the pathogenesis of Parkinson's diseaseJeswinder Sian-Hülsmann, Silvia Mandel, Moussa B H Youdim, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|December 1, 2007
Targeting multiple Alzheimer's disease etiologies with multimodal neuroprotective and neurorestorative iron chelatorsTamar Amit, Yael Avramovich-Tirosh, Moussa B H Youdim, et al.
Neurotoxicity Research|April 24, 2003
Early and late molecular events in neurodegeneration and neuroprotection in Parkinson's disease MPTP model as assessed by cDNA microarray; the role of ironMoussa B.H. Youdim, Edna Grünblatt, Yona Levites, et al.
Molecular Nutrition & Food Research|February 14, 2006
Green tea catechins as brain-permeable, natural iron chelators-antioxidants for the treatment of neurodegenerative disordersSilvia Mandel, Tamar Amit, Lydia Reznichenko, et al.
Antioxidants & Redox Signaling|January 26, 2010
Neuroprotective multifunctional iron chelators: from redox-sensitive process to novel therapeutic opportunitiesOrly Weinreb, Tamar Amit, Silvia Mandel, et al.
Journal of Alzheimer'S Disease : JAD|June 18, 2010
Propargylamine containing compounds as modulators of proteolytic cleavage of amyloid-beta protein precursor: involvement of MAPK and PKC activationOrit Bar-Am, Tamar Amit, Orly Weinreb, et al.
CNS Drugs|July 23, 2003
Neuroprotective strategies in Parkinson's disease : an update on progressSilvia Mandel, Edna Grünblatt, Peter Riederer, et al.
Pageof 5